PL3733171T3 - Kompozycje zawierające hmb i atp oraz ich zastosowanie - Google Patents
Kompozycje zawierające hmb i atp oraz ich zastosowanieInfo
- Publication number
- PL3733171T3 PL3733171T3 PL20169493.2T PL20169493T PL3733171T3 PL 3733171 T3 PL3733171 T3 PL 3733171T3 PL 20169493 T PL20169493 T PL 20169493T PL 3733171 T3 PL3733171 T3 PL 3733171T3
- Authority
- PL
- Poland
- Prior art keywords
- hmb
- atp
- compositions
- well
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261698919P | 2012-09-10 | 2012-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3733171T3 true PL3733171T3 (pl) | 2024-03-18 |
Family
ID=50237697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20169493.2T PL3733171T3 (pl) | 2012-09-10 | 2013-09-10 | Kompozycje zawierające hmb i atp oraz ich zastosowanie |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10092590B2 (pl) |
| EP (2) | EP3733171B1 (pl) |
| JP (1) | JP6258943B2 (pl) |
| CN (1) | CN105025891B (pl) |
| AU (1) | AU2013312113B2 (pl) |
| BR (1) | BR112015005199B1 (pl) |
| CA (1) | CA2884405C (pl) |
| DK (1) | DK3733171T3 (pl) |
| ES (1) | ES2970283T3 (pl) |
| FI (1) | FI3733171T3 (pl) |
| HK (1) | HK1217087A1 (pl) |
| PL (1) | PL3733171T3 (pl) |
| PT (1) | PT3733171T (pl) |
| WO (1) | WO2014040067A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2018145520A (ru) * | 2016-05-25 | 2020-06-25 | ТиЭсАй ГРУП ЛТД. | Стабилизация композиций бета-гидроксиизовалериановых кислот в мягких гелевых капсулах |
| US10888576B2 (en) * | 2018-10-08 | 2021-01-12 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028440A (en) | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
| US4992470A (en) | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
| NZ256300A (en) | 1992-09-16 | 1997-06-24 | Univ Iowa State Res Found Inc | Administration of beta-hydroxy-beta-methyl butyric acid, or its convertible forms, to lower cholesterol levels |
| US5348979A (en) | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
| US6031000A (en) | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| JP4010390B2 (ja) | 1999-09-20 | 2007-11-21 | 明治乳業株式会社 | 免疫賦活化組成物 |
| US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| US20050027005A1 (en) * | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
| US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| WO2006034586A1 (en) * | 2004-09-29 | 2006-04-06 | Aplodan Formulations Ltd. | Nutritional composition for promoting muscle performance and acting as hydrogen (h+) blocker |
| US20060073891A1 (en) * | 2004-10-01 | 2006-04-06 | Holt Timothy M | Display with multiple user privacy |
| CN101184496A (zh) | 2005-05-27 | 2008-05-21 | 兴和株式会社 | 用于恢复疲劳的药品 |
| WO2007108071A1 (ja) | 2006-03-17 | 2007-09-27 | Pharma Foods International Co., Ltd. | 抗ストレス組成物及びそれを含有する飲食品 |
| US8815280B2 (en) * | 2008-12-09 | 2014-08-26 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
| DE102009052640A1 (de) | 2009-11-10 | 2011-05-12 | Linde-Lkca-Dresden Gmbh | Verfahren und Vorrichtung zur Gaswäsche |
| HUE032486T2 (en) * | 2009-12-18 | 2018-05-02 | Metabolic Tech Inc | An improved method for administering beta-hydroxy-beta-methylbutyrate (HMB) |
-
2013
- 2013-09-10 WO PCT/US2013/059039 patent/WO2014040067A1/en active Application Filing
- 2013-09-10 US US14/023,162 patent/US10092590B2/en active Active
- 2013-09-10 ES ES20169493T patent/ES2970283T3/es active Active
- 2013-09-10 DK DK20169493.2T patent/DK3733171T3/da active
- 2013-09-10 CA CA2884405A patent/CA2884405C/en active Active
- 2013-09-10 BR BR112015005199-5A patent/BR112015005199B1/pt active IP Right Grant
- 2013-09-10 PT PT201694932T patent/PT3733171T/pt unknown
- 2013-09-10 PL PL20169493.2T patent/PL3733171T3/pl unknown
- 2013-09-10 EP EP20169493.2A patent/EP3733171B1/en active Active
- 2013-09-10 FI FIEP20169493.2T patent/FI3733171T3/fi active
- 2013-09-10 CN CN201380058560.6A patent/CN105025891B/zh active Active
- 2013-09-10 EP EP13835631.6A patent/EP2892522A4/en not_active Ceased
- 2013-09-10 JP JP2015531321A patent/JP6258943B2/ja active Active
- 2013-09-10 AU AU2013312113A patent/AU2013312113B2/en active Active
-
2016
- 2016-05-03 HK HK16105038.5A patent/HK1217087A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1217087A1 (zh) | 2016-12-23 |
| EP2892522A1 (en) | 2015-07-15 |
| US20140080781A1 (en) | 2014-03-20 |
| JP6258943B2 (ja) | 2018-01-10 |
| EP3733171A1 (en) | 2020-11-04 |
| DK3733171T3 (da) | 2024-01-29 |
| WO2014040067A1 (en) | 2014-03-13 |
| AU2013312113B2 (en) | 2018-08-02 |
| PT3733171T (pt) | 2024-01-31 |
| CA2884405A1 (en) | 2014-03-13 |
| US10092590B2 (en) | 2018-10-09 |
| AU2013312113A1 (en) | 2015-03-26 |
| EP3733171B1 (en) | 2023-10-25 |
| ES2970283T3 (es) | 2024-05-27 |
| JP2015527408A (ja) | 2015-09-17 |
| CA2884405C (en) | 2021-03-30 |
| CN105025891B (zh) | 2020-01-21 |
| BR112015005199B1 (pt) | 2022-09-06 |
| CN105025891A (zh) | 2015-11-04 |
| FI3733171T3 (fi) | 2024-01-24 |
| EP2892522A4 (en) | 2016-01-20 |
| BR112015005199A2 (pt) | 2017-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252566A0 (en) | Pharmacy preparations and methods | |
| HK1213798A1 (zh) | 治療性化合物和組合物 | |
| IL236024A (en) | The history of benzimidazole-proline and its pharmaceutical preparations | |
| ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| IL269024A (en) | The trains containing PEG and ASCORBATE | |
| IL234628A0 (en) | Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs | |
| EP2836212A4 (en) | NOVEL COMPOSITIONS AND METHOD | |
| EP2884984A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD | |
| ZA201501124B (en) | Trans-clomiphene formulations and uses thereof | |
| EP2806872A4 (en) | BENDAMUSTIN COMPOSITIONS AND RELATED METHODS | |
| HK1216250A1 (zh) | '- '-羥基-二氫麥角胺化合物及組合物 | |
| GB201315350D0 (en) | Methods and compositions | |
| GB201315347D0 (en) | Methods and compositions | |
| EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
| EP2668044A4 (en) | COMPOSITIONS AND THEIR USE | |
| EP2852370A4 (en) | FLASH-CONTAINING COMPOSITIONS AND METHODS OF USE | |
| EP2895186A4 (en) | THERAPEUTIC COMPOSITIONS AND RELATED METHODS | |
| IL238461A0 (en) | 1 hindole-3-carboxamide derivatives and their use as p2y12 inhibitors | |
| HK1231520A1 (zh) | 改進的基質穩定性組合物和方法 | |
| HK1217087A1 (zh) | 的組合物及使用方法 | |
| EP2834635A4 (en) | COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR | |
| GB201208315D0 (en) | Pharmaceutical methods and compositions | |
| EP2838365A4 (en) | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | |
| GB201207064D0 (en) | Pharmaceutical compositions comprising 15-hetre and methods of using the same | |
| IL226913A0 (en) | Preparations containing natural extracts |